跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Dialexib 400 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Dialexib 400
Approved
STANDARD
Dialexib 400
Stallion Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c421ff3d0b4c0e29
Company
Stallion Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
c421ff3d0b4c0e29
Drug Approval Philippines Name
Dialexib 400
Product Name
Dialexib 400
Registration Number
DRP-4804-04
Brand Name
Dialexib 400
Generic Name
Celecoxib
Dosage Form
Capsule
Dosage Strength
400 mg
Manufacturer
Stallion Laboratories Pvt. Ltd.
Importer
Ambica International Trading Corp.
Distributor
Diafarm, Inc.
Issuance Date
28 February 2023
Expiry Date
11 October 2028
Pharmacologic Category
Selective COX-2 Inhibitor
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c421ff3d0b4c0e29
Type
Standard
Back to Philippines FDA Approvals